HomeCHRS • NASDAQ
add
Coherus Biosciences Inc
Previous close
$2.02
Day range
$1.91 - $2.03
Year range
$1.43 - $8.22
Market cap
219.05M USD
Avg Volume
2.34M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 91.52M | 101.81% |
Operating expense | 71.36M | -13.65% |
Net income | -79.65M | -35.30% |
Net profit margin | -87.03 | 32.96% |
Earnings per share | -0.62 | -2.90% |
EBITDA | -89.34M | -77.11% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 117.75M | -38.57% |
Total assets | 629.60M | 30.94% |
Total liabilities | 823.03M | 33.12% |
Total equity | -193.42M | — |
Shares outstanding | 112.71M | — |
Price to book | -1.17 | — |
Return on assets | -37.25% | — |
Return on capital | -71.47% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -79.65M | -35.30% |
Cash from operations | -12.94M | 87.06% |
Cash from investing | 35.20M | 127.10% |
Cash from financing | 366.00K | -94.45% |
Net change in cash | 22.63M | 110.14% |
Free cash flow | -828.00K | 98.44% |
About
Founded
2010
Headquarters
Website
Employees
306